Edward Hurwitz - Net Worth and Insider Trading

Edward Hurwitz Net Worth

The estimated net worth of Edward Hurwitz is at least $489,164 dollars as of 2024-04-29. Edward Hurwitz is the Director of Macrogenics Inc and owns about 33,074 shares of Macrogenics Inc (MGNX) stock worth over $489,164. Details can be seen in Edward Hurwitz's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Edward Hurwitz has not made any transactions after 2023-08-30 and currently still holds the listed stock(s).

Transaction Summary of Edward Hurwitz

Edward Hurwitz Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Edward Hurwitz owns 12 companies in total, including Turmeric Acquisition Corp (TMPMU) , Dyne Therapeutics Inc (DYN) , and Macrogenics Inc (MGNX) among others .

Click here to see the complete history of Edward Hurwitz’s form 4 insider trades.

Insider Ownership Summary of Edward Hurwitz

Ticker	Comapny	Transaction Date	Type of Owner
TMPMU	Turmeric Acquisition Corp	2020-10-15	Chief Financial Officer
DYN	Dyne Therapeutics Inc	2020-09-16	director & 10 percent owner
MGNX	Macrogenics Inc	2023-08-30	director
AGTC	Applied Genetic Technologies Corp	2015-11-19	director
CARA	Cara Therapeutics Inc	2014-01-30	director & 10 percent owner
SNSS	Sunesis Pharmaceuticals Inc	2013-06-28	director
AEGR	Aegerion Pharmaceuticals Inc	2012-10-15	10 percent owner
MTEM	Molecular Templates Inc	2008-08-29	10 percent owner
RPTP	Raptor Pharmaceutical Corp	2009-09-03	other: No longer 10% owner
NGSX	NeurogesX Inc	2007-05-07	10 percent owner
VIRX	Viracta Therapeutics Inc	2009-06-18	director
TMPM	Turmeric Acquisition Corp	2020-10-15	Chief Financial Officer

Edward Hurwitz Latest Holdings Summary

Edward Hurwitz currently owns a total of 1 stock. Edward Hurwitz owns 33,074 shares of Macrogenics Inc (MGNX) as of August 30, 2023, with a value of $489,164.

Latest Holdings of Edward Hurwitz

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
MGNX	Macrogenics Inc	2023-08-30	33,074	14.79	489,164

Holding Weightings of Edward Hurwitz

Edward Hurwitz Form 4 Trading Tracker

According to the SEC Form 4 filings, Edward Hurwitz has made a total of 1 transactions in Macrogenics Inc (MGNX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Macrogenics Inc is the acquisition of 15,000 shares on August 30, 2023, which cost Edward Hurwitz around $73,650.

Insider Trading History of Edward Hurwitz

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Edward Hurwitz Trading Performance

GuruFocus tracks the stock performance after each of Edward Hurwitz's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Edward Hurwitz is 67.55%. GuruFocus also compares Edward Hurwitz's trading performance to market benchmark return within the same time period. The performance of stocks bought by Edward Hurwitz within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Edward Hurwitz's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Edward Hurwitz

Average Return

No transaction record over 1 year.

Outperforming Transactions

No transaction record over 1 year.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-4.9	67.55	288.98
Relative Return to S&P 500(%)	0.12	66.38	275.2

Edward Hurwitz Ownership Network

Ownership Network List of Edward Hurwitz

No Data

Ownership Network Relation of Edward Hurwitz

Edward Hurwitz Owned Company Details

What does Turmeric Acquisition Corp do?

Who are the key executives at Turmeric Acquisition Corp?

Edward Hurwitz is the Chief Financial Officer of Turmeric Acquisition Corp. Other key executives at Turmeric Acquisition Corp include Chief Executive Officer Luke Evnin , President Todd Foley , and 10 percent owner Turmeric Management, Llc .

Turmeric Acquisition Corp (TMPMU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Turmeric Acquisition Corp (TMPMU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Turmeric Acquisition Corp (TMPMU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Turmeric Acquisition Corp (TMPMU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Turmeric Acquisition Corp Insider Transactions

No Available Data

What does Dyne Therapeutics Inc do?

Who are the key executives at Dyne Therapeutics Inc?

Edward Hurwitz is the director & 10 percent owner of Dyne Therapeutics Inc. Other key executives at Dyne Therapeutics Inc include Chief Medical Officer Wildon Farwell , See Remarks Richard William Scalzo , and Chief Operating Officer Susanna Gatti High .

Dyne Therapeutics Inc (DYN) Insider Trades Summary

Over the past 18 months, Edward Hurwitz made no insider transaction in Dyne Therapeutics Inc (DYN). Other recent insider transactions involving Dyne Therapeutics Inc (DYN) include a net sale of 241,325 shares made by Jonathan Mcneill , a net sale of 191,946 shares made by Richard William Scalzo , and a net sale of 1,171,794 shares made by Joshua T Brumm .

In summary, during the past 3 months, insiders sold 4,521,380 shares of Dyne Therapeutics Inc (DYN) in total and bought 0 shares, with a net sale of 4,521,380 shares. During the past 18 months, 5,472,903 shares of Dyne Therapeutics Inc (DYN) were sold and 3,583,447 shares were bought by its insiders, resulting in a net sale of 1,889,456 shares.

Dyne Therapeutics Inc (DYN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Dyne Therapeutics Inc Insider Transactions

No Available Data

What does Macrogenics Inc do?

Who are the key executives at Macrogenics Inc?

Edward Hurwitz is the director of Macrogenics Inc. Other key executives at Macrogenics Inc include Acting General Counsel Jeffrey Stuart Peters , SVP & CFO and Secretary James Karrels , and Sr VP & BPD & Manufacturing Thomas Spitznagel .

Macrogenics Inc (MGNX) Insider Trades Summary

Over the past 18 months, Edward Hurwitz made 1 insider transaction in Macrogenics Inc (MGNX) with a net purchase of 15,000. Other recent insider transactions involving Macrogenics Inc (MGNX) include a net purchase of 1,700,000 shares made by Biotech Target N V , a net sale of 168,767 shares made by Jeffrey Stuart Peters , and a net sale of 48,846 shares made by Ezio Bonvini .

In summary, during the past 3 months, insiders sold 261,204 shares of Macrogenics Inc (MGNX) in total and bought 0 shares, with a net sale of 261,204 shares. During the past 18 months, 298,772 shares of Macrogenics Inc (MGNX) were sold and 1,715,000 shares were bought by its insiders, resulting in a net purchase of 1,416,228 shares.

Macrogenics Inc (MGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Macrogenics Inc Insider Transactions

No Available Data

What does Applied Genetic Technologies Corp do?

Who are the key executives at Applied Genetic Technologies Corp?

Edward Hurwitz is the director of Applied Genetic Technologies Corp. Other key executives at Applied Genetic Technologies Corp include Chief Medical Officer Susan Schneider , Chief Financial Officer Jonathan I Lieber , and See Remarks Stephen W Potter .

Applied Genetic Technologies Corp (AGTC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Applied Genetic Technologies Corp (AGTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Applied Genetic Technologies Corp (AGTC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Applied Genetic Technologies Corp (AGTC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Applied Genetic Technologies Corp Insider Transactions

No Available Data

What does Cara Therapeutics Inc do?

Who are the key executives at Cara Therapeutics Inc?

Edward Hurwitz is the director & 10 percent owner of Cara Therapeutics Inc. Other key executives at Cara Therapeutics Inc include Chief Medical Officer Joana Goncalves , Sec'y; Chief Compliance & G.C. Scott Terrillion , and VP-Research & Development Menzaghi Frederique Ph.d. .

Cara Therapeutics Inc (CARA) Insider Trades Summary

Over the past 18 months, Edward Hurwitz made no insider transaction in Cara Therapeutics Inc (CARA). Other recent insider transactions involving Cara Therapeutics Inc (CARA) include a net sale of 77,176 shares made by Christopher Posner , a net sale of 29,470 shares made by Joana Goncalves , and a net sale of 24,304 shares made by Scott Terrillion .

In summary, during the past 3 months, insiders sold 46,062 shares of Cara Therapeutics Inc (CARA) in total and bought 0 shares, with a net sale of 46,062 shares. During the past 18 months, 152,472 shares of Cara Therapeutics Inc (CARA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 152,472 shares.

Cara Therapeutics Inc (CARA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cara Therapeutics Inc Insider Transactions

No Available Data

What does Sunesis Pharmaceuticals Inc do?

Who are the key executives at Sunesis Pharmaceuticals Inc?

Edward Hurwitz is the director of Sunesis Pharmaceuticals Inc. Other key executives at Sunesis Pharmaceuticals Inc include director & See Remarks Dayton Misfeldt , VP & Finance Tina Gullotta , and See Remarks William P. Quinn .

Sunesis Pharmaceuticals Inc (SNSS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sunesis Pharmaceuticals Inc (SNSS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sunesis Pharmaceuticals Inc (SNSS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sunesis Pharmaceuticals Inc (SNSS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sunesis Pharmaceuticals Inc Insider Transactions

No Available Data

What does Aegerion Pharmaceuticals Inc do?

Who are the key executives at Aegerion Pharmaceuticals Inc?

Edward Hurwitz is the 10 percent owner of Aegerion Pharmaceuticals Inc. Other key executives at Aegerion Pharmaceuticals Inc include director & Chief Executive Officer Mary T Szela , other: See Remarks Gregory D Perry , and 10 percent owner Broadfin Healthcare Master Fund Ltd .

Aegerion Pharmaceuticals Inc (AEGR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aegerion Pharmaceuticals Inc (AEGR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aegerion Pharmaceuticals Inc (AEGR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aegerion Pharmaceuticals Inc (AEGR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aegerion Pharmaceuticals Inc Insider Transactions

No Available Data

What does Molecular Templates Inc do?

Who are the key executives at Molecular Templates Inc?

Edward Hurwitz is the 10 percent owner of Molecular Templates Inc. Other key executives at Molecular Templates Inc include 10 percent owner Biotech Target N V , Chief Medical Officer Maurizio Voi , and CFO & Treasurer Sean Mclennan .

Molecular Templates Inc (MTEM) Insider Trades Summary

Over the past 18 months, Edward Hurwitz made no insider transaction in Molecular Templates Inc (MTEM). Other recent insider transactions involving Molecular Templates Inc (MTEM) include a net purchase of 4,505,319 shares made by Biotech Target N V ,

In summary, during the past 3 months, insiders sold 0 shares of Molecular Templates Inc (MTEM) in total and bought 250,000 shares, with a net purchase of 250,000 shares. During the past 18 months, 0 shares of Molecular Templates Inc (MTEM) were sold and 533,688 shares were bought by its insiders, resulting in a net purchase of 533,688 shares.

Molecular Templates Inc (MTEM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Molecular Templates Inc Insider Transactions

No Available Data

What does Raptor Pharmaceutical Corp do?

Who are the key executives at Raptor Pharmaceutical Corp?

Edward Hurwitz is the other: No longer 10% owner of Raptor Pharmaceutical Corp. Other key executives at Raptor Pharmaceutical Corp include Chief Medical Officer Krishna R Polu , Chief Financial Officer Michael P Smith , and Chief Commercial Officer David Happel .

Raptor Pharmaceutical Corp (RPTP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Raptor Pharmaceutical Corp (RPTP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Raptor Pharmaceutical Corp (RPTP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Raptor Pharmaceutical Corp (RPTP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Raptor Pharmaceutical Corp Insider Transactions

No Available Data

What does NeurogesX Inc do?

Who are the key executives at NeurogesX Inc?

Edward Hurwitz is the 10 percent owner of NeurogesX Inc. Other key executives at NeurogesX Inc include President and CEO Ron Martell , Exec. V.P. & COO & CFO Stephen F Ghiglieri , and director & 10 percent owner Robert Nelsen .

NeurogesX Inc (NGSX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of NeurogesX Inc (NGSX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NeurogesX Inc (NGSX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NeurogesX Inc (NGSX)'s detailed insider trading history can be found in Insider Trading Tracker table.

NeurogesX Inc Insider Transactions

No Available Data

What does Viracta Therapeutics Inc do?

Who are the key executives at Viracta Therapeutics Inc?

Edward Hurwitz is the director of Viracta Therapeutics Inc. Other key executives at Viracta Therapeutics Inc include Chief Executive Officer Daniel R. Chevallard , director & President and CEO Mark Rothera , and Chief Medical Officer Darrel P. Cohen .

Viracta Therapeutics Inc (VIRX) Insider Trades Summary

Over the past 18 months, Edward Hurwitz made no insider transaction in Viracta Therapeutics Inc (VIRX). Other recent insider transactions involving Viracta Therapeutics Inc (VIRX) include a net sale of 21,403 shares made by Daniel R. Chevallard , a net sale of 4,272 shares made by Lisa Rojkjaer , and a net purchase of 100,000 shares made by Mark Rothera .

In summary, during the past 3 months, insiders sold 3,405 shares of Viracta Therapeutics Inc (VIRX) in total and bought 0 shares, with a net sale of 3,405 shares. During the past 18 months, 25,675 shares of Viracta Therapeutics Inc (VIRX) were sold and 100,000 shares were bought by its insiders, resulting in a net purchase of 74,325 shares.

Viracta Therapeutics Inc (VIRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Viracta Therapeutics Inc Insider Transactions

No Available Data

What does Turmeric Acquisition Corp do?

Who are the key executives at Turmeric Acquisition Corp?

Turmeric Acquisition Corp (TMPM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Turmeric Acquisition Corp (TMPM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Turmeric Acquisition Corp (TMPM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Turmeric Acquisition Corp (TMPM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Turmeric Acquisition Corp Insider Transactions

No Available Data

Edward Hurwitz Mailing Address

Above is the net worth, insider trading, and ownership report for Edward Hurwitz. Currently GuruFocus does not have mailing address information for Edward Hurwitz.

Discussions on Edward Hurwitz

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.